✉news TechnologyAI first seen 1 d ago, last 1 d ago, peak #32
Survey finds compliance concerns slowing AI adoption in drug manufacturing
Original: Compliance concerns hinder rollout of AI in drug manufacturing: Survey
A new survey covered by BioSpace indicates that regulatory compliance worries are holding back the adoption of artificial intelligence in pharmaceutical manufacturing. Drugmakers see potential in AI to improve efficiency and quality control, but uncertainty around meeting regulatory requirements and validation standards is delaying wider rollout across production facilities, according to the findings.
Why now: AI adoption in regulated industries is a hot topic, and this survey quantifies the compliance barriers facing pharma manufacturers.
BioSpacepharmaceutical industryAI in manufacturing
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1243475